Latest about vaccines
RSV vaccine keeps older adults highly protected for at least 2 seasons
Pfizer's recently approved RSV vaccine maintains a high and fairly steady rate of effectiveness across consecutive RSV seasons.
Rare clotting effect of early COVID shots finally explained — what could that mean for future vaccines?
Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.
Vaccine for superbugs? New shot shows promise in early tests
A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.
Measles deaths jumped over 40% from 2021 to 2022, CDC reports
Declines in measles vaccination during the COVID-19 pandemic have been tied to an uptick in measles cases, deaths and major outbreaks worldwide.
FDA approves world's 1st chikungunya vaccine
There's now an FDA-approved vaccine for chikungunya, a mosquito-spread virus that can cause fever, severe joint pain, and rarely, death.
Who should get the new COVID vaccines? What to know about the 2023-2024 shots
New COVID vaccines have been approved to guard against coronavirus variants that are currently circulating.
Novavax's new COVID vaccine cleared for use by FDA
An updated COVID-19 vaccine made by Novavax has been authorized by the FDA, joining the two vaccines already cleared for use.
Inexpensive new malaria vaccine is a 'vital tool' to protect tens of millions of people
The World Health Organization has recommended the use of a malaria vaccine called Matrix-M, which is anticipated to boost the vaccine supply.
